| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:c-ABL-IN-2
CAS:2574593-54-5
Package:1removed
|
Benzamide, 4-methyl-N-[1-(1-methylethyl)-1H-imidazol-4-yl]-3-[2-(3-pyridinyl)ethynyl]- manufacturers
- c-ABL-IN-2
-
- $1520.00
-
2026-04-20
- CAS:2574593-54-5
- Purity:
- Supply Ability: 10g
|
| | Benzamide, 4-methyl-N-[1-(1-methylethyl)-1H-imidazol-4-yl]-3-[2-(3-pyridinyl)ethynyl]- Basic information |
| | Benzamide, 4-methyl-N-[1-(1-methylethyl)-1H-imidazol-4-yl]-3-[2-(3-pyridinyl)ethynyl]- Chemical Properties |
| Boiling point | 531.4±50.0 °C(Predicted) | | density | 1.13±0.1 g/cm3(Predicted) | | pka | 12.74±0.70(Predicted) |
| | Benzamide, 4-methyl-N-[1-(1-methylethyl)-1H-imidazol-4-yl]-3-[2-(3-pyridinyl)ethynyl]- Usage And Synthesis |
| Uses | c-ABL-IN-2 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-2 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2020260871A1, compound 25)[1]. c-ABL-IN-2 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | | References | [1] Rebecca PAUL, et al. New compounds and methods. Patent WO2020260871A1. |
| | Benzamide, 4-methyl-N-[1-(1-methylethyl)-1H-imidazol-4-yl]-3-[2-(3-pyridinyl)ethynyl]- Preparation Products And Raw materials |
|